{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:efitazanamivir alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:rilvegostomig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anivovetmab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:carocovatein [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pamlectabart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04085523: Phase 2 Interventional Completed Achondroplasia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:selcopintide [INN]
Source URL:
Class:
PROTEIN